- CA$364.09m
- CA$392.88m
- CA$38.97m
- 51
- 14
- 59
- 36
Annual income statement for Healwell Al, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 38.6 | 47.8 | 10.4 | 7.32 | 39 |
| Cost of Revenue | |||||
| Gross Profit | 12.9 | 15 | 3.71 | 1.26 | 17.3 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 41.9 | 64.3 | 27.7 | 37.2 | 67.2 |
| Operating Profit | -3.29 | -16.4 | -17.3 | -29.9 | -28.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.34 | -16.3 | -17.1 | -32.7 | -28.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.03 | -15.5 | -18.2 | -32.1 | -27.4 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -1.03 | -15.7 | -21.1 | -31.6 | -26.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.03 | -15.7 | -21.1 | -31.6 | -26.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.001 | -0.34 | -0.368 | -0.415 | -0.204 |
| Dividends per Share |